1
Pharmacokinetic Study Evaluating Staccato® Alprazolam 1 mg Inhaler in Smokers Versus Non-Smokers
Condition(s):HealthyLast Updated:December 19, 2018Completed
Alprazolam: 94 Clinical Trials, Page 1 of 10
Hide Studies Not Open or Pending
2
Pharmacokinetics Of Alprazolam Sublingual Tablet Versus Conventional Tablet
Condition(s):Anxiety DisorderLast Updated:January 28, 2021Completed
3
Bioequivalence of Alprazolam Sublingual vs Oral Tablets
Condition(s):HealthyLast Updated:January 28, 2021Completed
4
Bioequivalence of a New Sublingual and a Reference Alprazolam Immediate Release Tablet Formulation
Condition(s):HealthyLast Updated:January 28, 2021Withdrawn
5
Bioequivalence Study Comparing Two Alprazolam 1 mg Tablets
Condition(s):HealthyLast Updated:November 25, 2009Completed
6
A Relative Bioavailability Study of 2 mg Alprazolam OD Tablets Under Fasting Conditions
Condition(s):HealthyLast Updated:August 25, 2010Completed
7
A Relative Bioavailability Study of 2 mg Alprazolam OD Tablets Under Non-Fasting Conditions
Condition(s):HealthyLast Updated:August 25, 2010Completed
8
Bioequivalence Study Comparing Two Alprazolam 1 mg Tablets Under Fed Conditions
Condition(s):HealthyLast Updated:November 25, 2009Completed
9
Bioequivalence of a New and a Commercial Alprazolam Sublingual Formulation
Condition(s):HealthyLast Updated:January 28, 2021Withdrawn
10
Role of Alprazolam in the Management of Acute Coronary Syndrome
Condition(s):Acute Coronary Syndrome; Myocardial Infarction; ST Elevation Myocardial Infarction; Heart Diseases; AnxietyLast Updated:January 20, 2021Recruiting